Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?

BACKGROUND: Women with polycystic ovary syndrome (PCOS) are at increased risk for cardiovascular (CV) and metabolic disorders. There is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy. In randomized trials, the administration of metform...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gharakhani, Mohsen, Neghab, Nosrat, Farimani, Marzie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Royan Institute 2011
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4059955/
https://ncbi.nlm.nih.gov/pubmed/24963365
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi